Jump to content

Recombinant human parathyroid hormone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Iaritmioawp (talk | contribs) at 23:04, 5 March 2015 (Added two categories.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Recombinant human parathyroid hormone, marketed under the trade name Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2]

References

  1. ^ "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". http://www.fda.gov/. Retrieved 30 January 2015. {{cite web}}: External link in |website= (help)
  2. ^ "Natpara Approval History". drugs.com. Retrieved 30 January 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Recombinant_human_parathyroid_hormone&oldid=650063957"